We found that an increased likelihood of developing long COVID in pediatric patients was also associated with specific alterations in laboratory parameters, most notably thrombocytosis, neutrophilia, and deviations in prothrombin time, including both shortened and prolonged values. The gene discussed is F2; the disease is Thrombocytosis.